ACE and age-related macular degeneration: examined the use of several systemic medications—including beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers—among patients with NV AMD and those with NNV AMD, finding no difference in usage rates between the two groups (11).